0000905148-19-000821.txt : 20190820
0000905148-19-000821.hdr.sgml : 20190820
20190820163349
ACCESSION NUMBER: 0000905148-19-000821
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190816
FILED AS OF DATE: 20190820
DATE AS OF CHANGE: 20190820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLENVIEW CAPITAL MANAGEMENT, LLC
CENTRAL INDEX KEY: 0001138995
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 191040029
BUSINESS ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
BUSINESS PHONE: 2128124700
MAIL ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
FORMER NAME:
FORMER CONFORMED NAME: GLENVIEW CAPITAL MANAGEMENT LLC
DATE OF NAME CHANGE: 20010420
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
X0306
4
2019-08-16
0000070318
TENET HEALTHCARE CORP
THC
0001138995
GLENVIEW CAPITAL MANAGEMENT, LLC
767 FIFTH AVENUE
44TH FLOOR
NEW YORK
NY
10153
true
Common Stock, $0.05 par value
2019-08-16
4
P
0
26456
19.8153
A
19357891
I
See footnotes
Common Stock, $0.05 par value
52394
D
These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were purchased by Glenview Capital Partners, L.P. and Glenview Capital Master Fund, Ltd. in the following amounts: 2,783 Shares were purchased by Glenview Capital Partners, L.P. and 23,673 were purchased by Glenview Capital Master Fund, Ltd.
These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.
Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on August 16, 2019 within a $1.00 range. The actual prices for these transactions range from $19.62 to $19.99, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price.
Includes 25,728 vested restricted stock units ("RSUs") that will be settled in Shares on May 5, 2020. Each RSU is the economic equivalent of one Share.
/s/ Mark J. Horowitz, Co-President of Glenview Capital Management, LLC
2019-08-20
/s/ Mark J. Horowitz, attorney-in-fact for Larry Robbins
2019-08-20